Spectroscopy in Parkinson Disease

Status unconfirmed

Conditions studied: Parkinson Disease

In brief

The primary objective of the study is to determine the utility of blood plasma infrared spectroscopy (biospectroscopy) in distinguishing subjects with idiopathic Parkinson's disease from healthy controls.

Key facts

Study ID

NCT01005030

Run by

Molecular Biometrics, Inc.

People needed

500

Starts

2009-10-01

Expected to finish

2014-03-01

Last updated by the study team

2009-11-10

Who can join

Age: 46 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• PD Subjects:
• PostCEPT subjects with a diagnosis of PD based on UK Brain Bank criteria.
• Willing and able to provide informed consent.
• Healthy Controls:
• No current diagnosis or known history of a neurological disease/disorder.
• Non-blood relative of a patient or subject at the site who has diagnosis of PD (may include healthy controls from the PROBE study).
• No first degree relatives with diagnosis of PD
• MoCA score > 26.
• Age > 45.
• Willing and able to provide informed consent.

Where it is running

• University of Rochester — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.